Biotech

All Articles

Arrowhead fires off period 3 data in rare metabolic condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own hand in front of a prospective face-off along with ...

Pfizer, Valneva present lyme disease chance helpful for 2nd enhancer

.Pfizer and also Valneva may possess concerning two more years to wait prior to they make the first ...

Fierce Biotech Editor-in-Chief Ayla Ellison Talks Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a discussion along with Ayla Ellison, Strong Biotech Managing Editor and Michelle...

New data show how Bayer's asundexian neglected to stop movements

.Bayer suspended the stage 3 trial for its variable XIa prevention asundexian behind time in 2013 af...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, execs hav...

Galapagos' stockpile as fund reveals intent to form its own advancement

.Galapagos is happening under additional tension coming from financiers. Having constructed a 9.9% r...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of significant management hirings, firings as we...

Allist pays Jacobio $21M, landing job in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has purchased on its own a starring character in China's KRAS marke...

ReNeuron leaving AIM exchange after missing out on fundraising objective

.ReNeuron has actually joined the long listing of biotechs to leave Greater london's AIM stock marke...

MBX declare IPO to take challenger to Ascendis right into stage 3

.MBX Biosciences has included in the latest outbreak of IPO filings. The biotech, which filed its ow...